Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.

Saved in:

Bibliographic Details
Title:	Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
Authors:	Nijs M; Janssen Research and Development, LLC, Department of Global Analytics - Neuroscience, Titusville., Wajs E; Janssen Research and Development, Belgium, Department of Neuroscience, Beerse, Belgium., Aluisio L; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA., Turkoz I; Janssen Research and Development, LLC, Department of Statistics & Decision Sciences, Titusville, NJ., Daly E; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ., Janik A; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA., Borentain S; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ., Singh JB; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA., DiBernardo A; Janssen Research and Development, France, Department of Clinical Medical Affairs, Issy-les-Moulineaux, France., Wiegand F; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ.
Source:	The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2020 Jul 29; Vol. 23 (7), pp. 426-433.
Publication Type:	Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1469-5111
DOI:	10.1093/ijnp/pyaa027